» Authors » Andrea Szegedi

Andrea Szegedi

Explore the profile of Andrea Szegedi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 93
Citations 1041
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
31.
Janka E, Vanyai B, Dajnoki Z, Szabo I, Reibl D, Komka I, et al.
Eur J Cancer Prev . 2021 Sep; 31(4):377-384. PMID: 34545023
Background: The incidence of cutaneous melanoma has risen faster than almost any other type of cancer in the last 50 years. Ultraviolet (UV) radiation and genetic susceptibility are the most...
32.
Zuberbier T, Abdul Latiff A, Abuzakouk M, Aquilina S, Asero R, Baker D, et al.
Allergy . 2021 Sep; 77(3):734-766. PMID: 34536239
This update and revision of the international guideline for urticaria was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group....
33.
Szentkereszty-Kovacs Z, Gaspar K, Szegedi A, Kemeny L, Kovacs D, Torocsik D
Int J Mol Sci . 2021 Jun; 22(9). PMID: 34067223
Alcohol affects the symptoms, compliance and comorbidities as well as the safety and efficacy of treatments in psoriatic patients. In this review, we aim to summarize and link clinical observations...
34.
Torocsik D, Fazekas F, Poliska S, Gregus A, Janka E, Dull K, et al.
Front Immunol . 2021 May; 12:600017. PMID: 34025636
Epidermal growth factor (EGF) acts as a paracrine and autocrine mediator of cell proliferation and differentiation in various types of epithelial cells, such as sebocytes, which produce the lipid-rich sebum...
35.
Jenei A, Kallo G, Dajnoki Z, Gaspar K, Szegedi A, Kapitany A, et al.
Int J Mol Sci . 2021 Apr; 22(8). PMID: 33921817
Antimicrobial and immunomodulatory peptides (AMPs) are considered as the key players in the maintenance of skin barrier functions. Here, we developed a novel approach for the examination of AMPs in...
36.
Rencz F, Mitev A, Szabo A, Beretzky Z, Poor A, Hollo P, et al.
Qual Life Res . 2021 Mar; 30(8):2375-2386. PMID: 33683650
Purpose: Eight of the ten items of the Dermatology Life Quality Index (DLQI) have a 'not relevant' response (NRR) option. There are two possible ways to interpret NRRs: they may...
37.
Gaspar K, Gergely L, Jenei B, Wikonkal N, Kinyo A, Szegedi A, et al.
Expert Rev Pharmacoecon Outcomes Res . 2021 Feb; 22(3):399-408. PMID: 33629618
Background: Hidradenitis suppurativa (HS) is a, chronic skin disease affecting up to 1% of the population in Europe. This study aims to assess the cost-of-illness of HS from a societal...
38.
Bato A, Brodszky V, Gergely L, Gaspar K, Wikonkal N, Kinyo A, et al.
Qual Life Res . 2021 Feb; 30(5):1477-1490. PMID: 33534032
Purpose: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that affects up to 1% of the population in Europe. The EQ-5D is the most commonly used generic instrument for...
39.
Fagyas M, Kertesz A, Siket I, Banhegyi V, Kracsko B, Szegedi A, et al.
Geroscience . 2021 Jan; 43(1):19-29. PMID: 33469835
Coronavirus disease 2019 (COVID-19) has a high mortality in elderly patients with pre-existing cardiovascular diseases. The cellular receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the angiotensin-converting enzyme...
40.
Jenei Kluch L, Erdei I, Remenyik E, Suranyi E, Bodnar F, Emri G, et al.
Orv Hetil . 2020 Nov; 161(46):1959-1965. PMID: 33190127
Összefoglaló. Két fiatal nőbetegnél a valproátról lamotriginre történő gyógyszerátállítás során a 3-4. héten influenzaszerű prodromalis tüneteket követően toxikus epidermalis necrolysis (TEN), más néven Lyell-szindróma alakult ki. Mindkét beteg 5 napja...